Background: The beneficial effects of immunocell therapy, using either activated
lymphocytes (ALs) or dendritic cells (DCs), in the treatment of melanoma has been …

An alternative strategy for cancer treatment is the manipulation of the immune system,
denominated cancer immunotherapy. The immunotherapeutical use of cells of the immune …

Melanoma is a particularly aggressive malignant tumour of the skin that is influenced by
genetic, environmental and physiological elements. Since current therapy for melanoma is …

Dendritic cell (DC)-based therapy has proved to be effective in patients with a variety of
malignancies. However, an optimal immunization protocol using DCs and the best means …

Previous studies have suggested that immunotherapy with dendritic cell (DC) vaccines may
be effective in treatment of patients with AJCC stage IV melanoma. We examined this …

Background In the present study, we have examined whether treatment of patients with
metastatic melanoma with matured dendritic cell (DC) vaccines with or without low dose IL-2 …

Background aims Dendritic cells are regarded as the most effective antigen presenting cells
and coordinators of the immune response and therefore suitable as vaccine basis. Here we …

Dendritic cells as immunotherapeutic agents against malignancies have been applied for
over ten years. Proof of principle studies demonstrated immunogenicity of dendritic cells …

Eleven AJCC stage IV melanoma patients with progressive disease after treatment with
biochemotherapy were treated with autologous dendritic cells pulsed with heterologous …

Dendritic cells (DC) are professional antigen‐presenting cells in the immune system which
are able to induce primary T‐cell responses. Because of their central role in the initiation of …